Biologics Business Strategy Cage Match: Wise Investments for Biologics and Biosimilars in the U.S.

Venable Fitzpatrick partners Scott K. Reed and Ha Kung Wong will speak on a panel, "Biologics Business Strategy Cage Match: Wise Investments for Biologics and Biosimilars in the U.S.," at The Westin Grand Munich on October 16. Panel topics will also include in-house and judicial perspectives on SPC, a European Patent Office keynote on antibodies, and practical perspectives on gene editing patenting. For more information on this summit, please click here.